NCT01439685 Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP Status WITHDRAWN Phase N/A
NCT01438554 Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma Status COMPLETED Phase PHASE1
NCT01438385 Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders Status UNKNOWN Phase N/A
NCT01434459 Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin Status TERMINATED Phase PHASE1
NCT01392274 pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture Status COMPLETED Phase N/A
NCT01303159 Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer Status TERMINATED Phase NA
NCT01290536 Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Status COMPLETED Phase PHASE2
NCT01267344 A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC Status COMPLETED Phase PHASE2
NCT01253148 Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma Status COMPLETED Phase NA
NCT01247337 Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT01242605 ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer Status COMPLETED Phase PHASE1
NCT01213758 Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT Status COMPLETED Phase N/A
NCT01206049 Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations Status COMPLETED Phase PHASE2
NCT01151761 Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation Status TERMINATED Phase PHASE2
NCT01135732 Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy Status COMPLETED Phase N/A
NCT01043172 A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection Status COMPLETED Phase PHASE2
NCT01007552 A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts Status COMPLETED Phase PHASE2
NCT00975039 Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma Status TERMINATED Phase PHASE2